Henrik T Sorensen, MD, PhD
Adjunct Professor
Boston University School of Public Health
Dept of Epidemiology

Henrik Toft Sørensen is professor of clinical epidemiology, and is founder and chair of Department of Clinical Epidemiology at Aarhus University Hospital, which was established in 2000. He is a physician and specialist in internal medicine and hepatology, has trained at several major Danish hospitals and acted as a clinician until 2005.

Dr. Sørensen has more than 25 years of experience in clinical and epidemiological research. His research covers, among others, pharmacoepidemiology, epidemiological measures and determinants of the prognosis of several chronic diseases. Dr. Sørensen is author or co-author of more than 1,150 publications and has been supervisor for more than 50 doctoral students.He is member of the Board of Directors of the Danish Council for Independent Research and Editor in Chief of Clinical Epidemiology.

Aarhus University Hospital

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Holland-Bill L, Christiansen CF, Ulrichsen SP, Ring T, Lunde Jørgensen JO, Sørensen HT. Preadmission Diuretic Use and Mortality in Patients Hospitalized With Hyponatremia: A Propensity Score-Matched Cohort Study. Am J Ther. 2019 Jan/Feb; 26(1):e79-e91. PMID: 28005557; DOI: 10.1097/MJT.0000000000000544;.
  2. Gradus JL, Horváth-Puhó E, Lash TL, Ehrenstein V, Tamang S, Adler NE, Milstein A, Glymour MM, Henderson VW, Sørensen HT. Stress Disorders and Dementia in the Danish Population. Am J Epidemiol. 2018 Dec 20.View Related Profiles. PMID: 30576420.
  3. van Rein N, Heide-Jørgensen U, Lijfering WM, Dekkers OM, Sørensen HT, Cannegieter SC. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study. Circulation. 2018 Dec 05. PMID: 30586754.
  4. Chung BI, Hellfritzsch M, Ulrichsen SP, Sørensen HT, Ehrenstein V. Bisphosphonate use and risk of renal cell carcinoma: A population-based case-control study. Basic Clin Pharmacol Toxicol. 2018 Nov 25. PMID: 30472809.
  5. Hjorth CF, Nielsen AS, Sørensen HT, Lash TL, Damkier P, Hamilton-Dutoit S, Cronin-Fenton D. Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study. Acta Oncol. 2018 Nov 20; 1-7. PMID: 30458661.
  6. Lunde A, Tell GS, Pedersen AB, Scheike T, Apalset EM, Ehrenstein V, Sørensen HT. The Role of Comorbidity on Mortality after Hip Fracture: A Nationwide Norwegian Study of 38,126 Women with Hip Fracture Matched to a General Population Comparison Cohort. Am J Epidemiol. 2018 Nov 08. PMID: 30407488.
  7. Skajaa N, Horváth-Puhó E, Sundbøll J, Adelborg K, Rothman KJ, Sørensen HT. Forty-year Seasonality Trends in Occurrence of Myocardial Infarction, Ischemic Stroke, and Hemorrhagic Stroke. Epidemiology. 2018 11; 29(6):777-783.View Related Profiles. PMID: 30028346.
  8. Collin LJ, Cronin-Fenton DP, Ahern TP, Christensen KB, Damkier P, Hamilton-Dutoit S, Kjaersgaard A, Lauridsen KL, Yacoub R, Christiansen P, Sørensen HT, Lash TL. Expression of survivin does not appear to influence breast cancer recurrence risk. Acta Oncol. 2018 Oct 23; 1-8. PMID: 30351173.
  9. Kornum JB, Farkas DK, Sværke C, Severinsen MT, Thomsen RW, Sørensen HT. Cancer Risk and Prognosis after a Hospital Contact for an Elevated Erythrocyte Sedimentation Rate. Cancer Epidemiol Biomarkers Prev. 2019 Jan; 28(1):225-232. PMID: 30352816.
  10. Ehrenstein V, Kristensen NR, Monz BU, Clinch B, Kenwright A, Sørensen HT. Oseltamivir in pregnancy and birth outcomes. BMC Infect Dis. 2018 Oct 16; 18(1):519. PMID: 30326840.
Showing 10 of 1163 results. Show More